The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Agaeva R.A.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Danilov N.M.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Shelkova G.V.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Sagaydak O.V.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Matchin Yu.G.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Chazova I.E.

Federal State budget organization National Medical Research Center of Cardiology of the Ministry of healthcare of the Russian Federation, The Institute of Clinical Cardiology, Moscow, Russia

The role of intervention methods of treatment of patients with resistant hypertension in contemporary cardiology

Authors:

Agaeva R.A., Danilov N.M., Shelkova G.V., Sagaydak O.V., Matchin Yu.G., Chazova I.E.

More about the authors

Journal: Russian Cardiology Bulletin. 2018;13(2): 22‑25

Read: 1339 times


To cite this article:

Agaeva RA, Danilov NM, Shelkova GV, Sagaydak OV, Matchin YuG, Chazova IE. The role of intervention methods of treatment of patients with resistant hypertension in contemporary cardiology. Russian Cardiology Bulletin. 2018;13(2):22‑25. (In Russ.)
https://doi.org/10.17116/Cardiobulletin201813222

References:

  1. Matchin YuG, Grigin VA, Danilov NM. Radiofrequency denervation of the renal arteries in the treatment of refractory arterial hypertension is the result of a yearly observation. Atmosfera. Novosti kardiologii. 2013;3:12-18. (In Russ.)
  2. Grigin VA, Danilov NM, Matchin YuG, Chazova IE. Radiofrequency denervation of the renal arteries. Myth or reality? Sistemnye gipertenzii. 2015;12(3):39-45. (In Russ.)
  3. Danilov NM, Matchin YuG, Chazova IE. Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension: first experience in Russia. Angiologiya i sosudistaya khirurgiya. 2012;18(1):51-54. (In Russ.)
  4. Agaeva RA, Danilov NM, Shelkova GV, Sagaydak ОV, Matchin UG, Chazova IЕ. Clinical case: Multi-Electrode Renal Denervation For treatment of patient with Resistant Hypertension. Kardiologicheskii vestnik. 2017;13(2):76-79. (In Russ.)
  5. Grigin VA, Danilov NM, Matchin YuG, Shchelkova GV, Chazova IE. Radiofrequency denervation of the renal arteries: waiting for answers. Systemnye gipertenzii. 2015;12(1):8-9. (In Russ.)
  6. Fu L Ng, Manish Saxena, Felix Mahfoud, Atul Pathak, Melvin D. Lobo; Device-based Therapy for Hypertension. Current Hypertension Reports. 2016;18:61. https://doi.org/10.1007/s11906-016-0670-5
  7. Device Based Therapy in Hypertension Trial (DEBuT-HT). 2003—2011.
  8. Briasoulis A, Bakris G. Efficacy of baroreflex activation therapy for the treatment of resistant hypertension. Euro Intervention. 2013;9(R):136-139. https://doi.org/10.4244/eijv9sra23
  9. Gordin D, Vikatmaa P, Vikatmaa L, Groop PH, Albäck A, Tikkanen I. Baroreflex activation therapy in the treatment of resistant hypertension Duodecim. 2016;132(20):1874-1881.
  10. Victor RG. Carotid baroreflex activation therapy for resistant hypertension. Nature Reviews Cardiology. 2015;12(8):451-463. https://doi.org/10.1038/nrcardio.2015.96
  11. Rheos Pivotal Trial: Rheos™ Baroreflex Hypertension Therapy System. 2006—2016.
  12. Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens. 2012;6(4):270-276. https://doi.org/10.1016/j.jash.2012.04.004
  13. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383(9917):622-629. https://doi.org/10.1016/S0140-6736(13)62192-3
  14. Sakakura K, Ladich E, Cheng Q. Anatomic assessment of sympathetic peri-arterial renal nerves in man. Journal of the American College of Cardiology. 2014;64(7):635-643. https://doi.org/10.1016/j.jacc.2014.03.059
  15. Bhatt D, Kandzari D, O׳Neill W. A controlled trial of renal denervation for resistant hypertension. New England Journal of Medicine. 2014;370:1393-1401. https://doi.org/10.1056/NEJMoa1402670
  16. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909. https://https://doi.org/ 10.1016/S0140-6736(10)62039-9
  17. Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J. 2014;35(26): 1752-1759. https://doi.org/10.1093/eurheartj/ehu209
  18. Shchelkova GV, Zairova AR, Danilov NM, Rogoza NM, Chazova IE. Arterial stifness and endothelial function in patients with resistant hypertension after renal denervation. Sistemnye gipertenzii. 2016;13(4):7-12. (In Russ.) https://doi.org/10.1097/01.hjh.0000491817.72712.2b
  19. Ripp TМ, Mordovin VF, Pekarskiy SE, Ryabova TV, Zlobina MZ, Semke GV, Falkovskaya AYu, Sitkova ES, Lichikaki VA, Krylov AL. Cardioprotective effects of renal denervation in resistant hypertension: efficienct predictors. Hypertension. 2014;20(6):560-567. (In Russ.)
  20. Pocock SJ, Bakris G, Bhatt DL, Brar S, Fahy M, Gersh BJ. Regression to the Mean in SYMPLICITY HTN-3: Implications for Design and Reporting of Future Trials. J Am Coll Cardiol. 2016;68(18):2016-2025. https://doi.org/10.1016/j.jacc.2016.07.775
  21. Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J. Bipolar radiofrequency renal denervation with the Vessix catheter in patients with resistant hypertension: 2-year results from the REDUCE-HTN trial. J Hum Hypertens. 2017;31(5):366-368. https://doi.org/10.1038/jhh.2016.82
  22. Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M. SPYRAL HTN-OFF MED trial investigators*. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390(10108): 2160-2170. https://doi.org/10.1016/S0140-6736(17)32281-X
  23. Kapil V, Sobotka P, Saxena M, Mathur A, Knight C, Dolan E, Stanton A, Lobo MD. Central Iliac Arteriovenous Anastomosis for Hypertension: Targeting Mechanical Aspects of the Circulation. Current Hypertension Reports. 2015;17(9):73.
  24. Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Schmieder RE. Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial Hypertension. Lancet. 2015;385(9978):1634-1641. https://doi.org/10.1016/S0140-6736(14)62053-5
  25. Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Schmieder RE. Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial. Hypertension. 2017;70(6):1099-1105. https://doi.org/10.1161/HYPERTENSIONAHA.117.10142
  26. Paivanas N, Bisognano JD, Gassler JP. Carotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant Hypertension. Methodist DeBakey Cardiovascular. 2015;11(4):223-227. https://doi.org/10.14797/mdcj-11-4-223

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.